The FDA has approved the proximal hypoglossal nerve stimulation device (aura6000 system) developed by LivaNova for adults ...
A tiny change at the boundary between two oxide layers may point to a less power-hungry future for artificial intelligence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results